Rankings
▼
Calendar
MNKD Q3 2016 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$869M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$162M
Gross Profit
$135M
83.3% margin
Operating Income
$118M
72.8% margin
Net Income
$127M
77.9% margin
EPS (Diluted)
$1.31
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$96M
Total Liabilities
$335M
Stockholders' Equity
-$239M
Cash & Equivalents
$36M
← FY 2016
All Quarters
Q4 2016 →